Leonteq Securities AG’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-25,000
Closed -$1.8M 1220
2022
Q4
$1.8M Hold
25,000
0.07% 216
2022
Q3
$1.78M Hold
25,000
0.07% 197
2022
Q2
$1.93M Buy
+25,000
New +$1.9M 0.07% 199

Other funds holding BMY

Leonteq Securities AG's BMY Position: Q2 2026 in Review

Leonteq Securities AG reduced its Bristol-Myers Squibb (BMY) stake by 89% in Q2 2026, selling an estimated $5.74M and leaving 12,628 shares worth $728K. The position accounts for 0.03% of the portfolio, ranked #320.

Leonteq Securities AG first reported a position in BMY in Q1 2021 and has held it in 19 quarters since. The position peaked at $6.83M in Q1 2026. 953 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Leonteq Securities AG held 12,628 shares of Bristol-Myers Squibb worth $728K as of Q2 2026.
  • Leonteq Securities AG sold 100,037 Bristol-Myers Squibb shares in Q2 2026, an estimated $5.74M.
  • Bristol-Myers Squibb made up 0.03% of Leonteq Securities AG's portfolio in Q2 2026, its #320 holding.
  • Leonteq Securities AG first reported a position in Bristol-Myers Squibb in Q1 2021 and has held it in 19 quarters since.
  • Leonteq Securities AG's Bristol-Myers Squibb position peaked at $6.83M in Q1 2026.
  • 953 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Leonteq Securities AG's 13F filing for Q2 2026, filed 27 Jul 2026.